PMV Pharmaceuticals (PMVP) Treasury Shares (2019 - 2025)
PMV Pharmaceuticals' (PMVP) quarterly Treasury Shares came in at $907666.0 in Q1 2025, down 20.13% YoY from $1.1 million in Q1 2024, and little changed on a QoQ basis from $907665.0 in Q4 2024.
PMV Pharmaceuticals (PMVP) Treasury Shares (2019 - 2025) Analysis & Trends
PMV Pharmaceuticals (PMVP) has 6 years of Treasury Shares data on file, last reported at $907666.0 in Q1 2025.
- Quarterly Treasury Shares fell 20.13% year-over-year to $907666.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $907666.0 (down 20.13% YoY) and the FY2024 annual result came in at $907665.0, up 284.12% from the prior year.
- Treasury Shares was little changed at $907666.0 in Q1 2025, from $907665.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.1 million in Q1 2024 to a low of $236296.0 in Q4 2023.
- A 4-year average of $634161.4 and a median of $374899.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares slumped 36.97% — and 2024, when it jumped 284.12%.
- Tracing PMVP's Treasury Shares over 4 years: stood at $374899.0 in 2022, then slumped by 36.97% to $236296.0 in 2023, then jumped by 284.12% to $907665.0 in 2024, then advanced by 0.0% to $907666.0 in 2025.
- The last three Treasury Shares figures came in at $907666.0 (Q1 2025), $907665.0 (Q4 2024), and $907666.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | PMV Pharmaceuticals | 70.74 Mn | -8.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 907,666.00 |
| Mar 31, 2025 | 907,666.00 |
| Dec 31, 2024 | 907,665.00 |
| Dec 31, 2024 | 907,665.00 |
| Sep 30, 2024 | 907,666.00 |
| Sep 30, 2024 | 907,666.00 |
| Jun 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 236,296.00 |
| Dec 31, 2023 | 236,296.00 |
| Sep 30, 2023 | 244,064.00 |
| Sep 30, 2023 | 244,064.00 |
| Jun 30, 2023 | 374,899.00 |
| Jun 30, 2023 | 374,899.00 |
| Mar 31, 2023 | 374,899.00 |
| Mar 31, 2023 | 374,899.00 |
| Dec 31, 2022 | 374,899.00 |
| Dec 31, 2022 | 374,899.00 |